<DOC>
	<DOCNO>NCT02429804</DOCNO>
	<brief_summary>This pilot clinical trial study combine fluorine F 18 sodium fluoride ( NaF ) / fludeoxyglucose F 18 ( FDG ) positron emission tomography ( PET ) magnetic resonance imaging ( MRI ) measure response drug , radium Ra 223 dichloride ( Ra-223 ) , treat patient prostate cancer respond hormone therapy spread part body . Combining NaF/FDG simultaneous PET/MRI scan may help doctor accurately measure well patient respond treatment radium Ra 223 dichloride .</brief_summary>
	<brief_title>NaF/FDG PET/MRI Measuring Response Radium Ra 223 Dichloride Patients With Metastatic Hormone-Resistant Prostate Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Estimate performance simultaneous NaF/FDG PET/MRI prediction treatment response patient metastatic castrate resistant prostate cancer ( mCRPC ) . II . Estimate performance simultaneous NaF/FDG PET/MRI detection extra-skeletal disease progression treatment mCRPC patient . OUTLINE : Patients receive 18F NaF 18F FDG intravenously ( IV ) 30 seconds-1 minute undergo PET/MRI contrast-enhanced MRI 45-60 minute . Patients undergo image baseline , course 3 ( 12 week ) , course 6 ( 24 week ) treatment Ra-223 . After completion study , patient follow 12 month .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<mesh_term>Sodium Fluoride</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<mesh_term>Listerine</mesh_term>
	<mesh_term>Radium Ra 223 dichloride</mesh_term>
	<criteria>Provides write informed consent Diagnosed mCRPC painful bone metastasis , refer Xofigo ( radium Ra 223 dichloride ) Able remain still duration image procedure ( one hour ) Metallic implant</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>